‘Prostate Screening Saved My Life’—Is That Really True in Most Cases?

Derek Raghavan, MD, PhD, discusses the contentious issue of prostate-specific antigen (PSA) screening for prostate cancer, highlighted by a recent TV advertisement celebrating its benefits. Despite claims of life-saving outcomes, experts criticize the lack of overall survival benefits demonstrated in the European Prostate Cancer Study, questioning the utility of PSA in early-stage detection and its potential to cause harm. The commentary advocates for a balanced health policy regarding PSA screening amidst ongoing confusion in medical practice.